Questions About Cancer? 1-800-4-CANCER
  • Posted: 10/26/2012
NCI Cancer Center News

Models developed from the PLCO may help identify at-risk patients for adverse smoking outcomes

Risk prediction models developed from an ancillary study of the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO) may be useful in the public health sector for identifying individuals who are at risk for adverse smoking outcomes, such as relapse among former smokers and continued smoking among current smokers, and those who may benefit from relapse prevention and smoking cessation interventions, according to a study from the Lombardi Comprehensive Cancer Center at Georgetown University published October 26 in the Journal of the National Cancer Institute.

Click here to read full press release. 

###

NCI comprehensive cancer centers logo

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.